HSP90AA1 and malignant colon neoplasm: It is conceivable that the inhibitory effect of AUY922 on multiple protein kinases such as CRAF and EGFR would also contribute the combinatorial effect of HSP90 inhibitors and BRAF inhibitors in colon cancer cells [44].